Patient-Centric Formulations Emerge: How Pharma Firms Are Designing Cardiovascular Drugs for Better Adherence
Adherence to cardiovascular drug regimens remains a major challenge, with studies showing 30–50% of patients stop taking prescribed medications within a year. This gap drives poor outcomes and wasted healthcare resources, prompting pharma firms to rethink drug design. Patient-centric formulations—focused on ease of use, reduced side effects, and flexibility—are emerging as a...
0 Comments 0 Shares 367 Views 0 Reviews
MTSocial https://mtsocial.ir